Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine vs Bisoprolol in hypertensive postmenopausal women with osteopenia
NCT02355821Completed
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine
- Start
- Apr 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of moxonidine in hypertension (HTN) and osteopenia, sponsored by National Medical Research Center for Therapy and Preventive Medicine. Started Apr 2015; status: completed.
02
Drugs
moxonidine
03
Conditions
hypertension (HTN)osteopenia
Beyond the preview
Go deeper on NCT02355821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355821.